117 related articles for article (PubMed ID: 12608405)
1. [Increased myopia and metaporphosia in a 59-year old patient. Serous retinal detachment of the posterior pol after latanoprost administration].
Sauer S; Coracas A; Eckhardt C
Ophthalmologe; 2003 Jan; 100(1):62-3. PubMed ID: 12608405
[No Abstract] [Full Text] [Related]
2. Serous retinal detachment in the macula related to latanoprost use.
Ozkan B; Karabaş VL; Yüksel N; Cağlar Y
Int Ophthalmol; 2008 Oct; 28(5):363-5. PubMed ID: 17805489
[TBL] [Abstract][Full Text] [Related]
3. Central serous chorioretinopathy associated with topical latanoprost therapy.
Artunay O; Senel A; Sengul A; Rasier R; Bahcecioglu H
Ocul Immunol Inflamm; 2011 Dec; 19(6):453-5. PubMed ID: 22106918
[TBL] [Abstract][Full Text] [Related]
4. Latanoprost and brimonidine: therapeutic and physiologic assessment before and after oral nonsteroidal anti-inflammatory therapy.
Sponsel WE; Paris G; Trigo Y; Pena M; Weber A; Sanford K; McKinnon S
Am J Ophthalmol; 2002 Jan; 133(1):11-8. PubMed ID: 11755835
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis of randomised controlled trials comparing latanoprost with brimonidine in the treatment of open-angle glaucoma, ocular hypertension or normal-tension glaucoma.
Fung AT; Reid SE; Jones MP; Healey PR; McCluskey PJ; Craig JC
Br J Ophthalmol; 2007 Jan; 91(1):62-8. PubMed ID: 16956912
[TBL] [Abstract][Full Text] [Related]
6. Three-month comparison of brimonidine and latanoprost as adjunctive therapy in glaucoma and ocular hypertension patients uncontrolled on beta-blockers: tolerance and peak intraocular pressure lowering.
Simmons ST; Earl ML;
Ophthalmology; 2002 Feb; 109(2):307-14; discussion 314-5. PubMed ID: 11825814
[TBL] [Abstract][Full Text] [Related]
7. Brimonidine purite 0.1% versus brinzolamide 1% as adjunctive therapy to latanoprost in patients with glaucoma or ocular hypertension.
Day DG; Hollander DA
Curr Med Res Opin; 2008 May; 24(5):1435-42. PubMed ID: 18402717
[TBL] [Abstract][Full Text] [Related]
8. Serous detachment of macula in cystoid macular edema associated with latanoprost.
Ozdemir H; Karacorlu M; Karacorlu SA
Eur J Ophthalmol; 2008; 18(6):1014-6. PubMed ID: 18988179
[TBL] [Abstract][Full Text] [Related]
9. Brimonidine/Timolol: a viewpoint by Robert M. Feldman.
Feldman RM
Drugs Aging; 2006; 23(9):762-3. PubMed ID: 17020401
[No Abstract] [Full Text] [Related]
10. Choroidal detachment following extracapsular cataract extraction in a patient treated with latanoprost.
Gupta R; Vernon SA
Br J Ophthalmol; 2001 Oct; 85(10):1268. PubMed ID: 11599505
[No Abstract] [Full Text] [Related]
11. Effect of latanoprost 0.005% and brimonidine tartrate 0.2% on pulsatile ocular blood flow in normal tension glaucoma.
Liu CJ; Ko YC; Cheng CY; Chou JC; Hsu WM; Liu JH
Br J Ophthalmol; 2002 Nov; 86(11):1236-9. PubMed ID: 12386077
[TBL] [Abstract][Full Text] [Related]
12. Effect of latanoprost 0.005% and brimonidine 0.2% on intraocular pressure after phacoemulsification and intraocular lens implantation surgery.
Erdogan H; Toker MI; Arici MK; Topalkara A
Jpn J Ophthalmol; 2004; 48(6):600-1. PubMed ID: 15592790
[No Abstract] [Full Text] [Related]
13. Comparison of brimonidine with latanoprost in the adjunctive treatment of glaucoma. ALPHAGAN/XALATAN Study Group.
Simmons ST; Samuelson TW
Clin Ther; 2000 Apr; 22(4):388-99. PubMed ID: 10823361
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the efficacy and tolerability of brimonidine and latanoprost in adults with open-angle glaucoma or ocular hypertension: a three-month, multicenter, randomized, double-masked, parallel-group trial.
DuBiner HB; Mroz M; Shapiro AM; Dirks MS;
Clin Ther; 2001 Dec; 23(12):1969-83. PubMed ID: 11813932
[TBL] [Abstract][Full Text] [Related]
15. Changes in intraocular pressure and ocular perfusion pressure after latanoprost 0.005% or brimonidine tartrate 0.2% in normal-tension glaucoma patients.
Liu CJ; Ko YC; Cheng CY; Chiu AW; Chou JC; Hsu WM; Liu JH
Ophthalmology; 2002 Dec; 109(12):2241-7. PubMed ID: 12466165
[TBL] [Abstract][Full Text] [Related]
16. The efficacy and safety of latanoprost 0.005% once daily versus brimonidine 0.2% twice daily in open-angle glaucoma or ocular hypertension.
Stewart WC; Day DG; Stewart JA; Schuhr J; Latham KE
Am J Ophthalmol; 2001 May; 131(5):631-5. PubMed ID: 11336939
[TBL] [Abstract][Full Text] [Related]
17. Macular edema associated with latanoprost use in a patient with idiopathic juxtafoveal retinal telangiectasis.
Baba T; Nagayama M; Ohtsuki H; Hirooka K; Shiraga F
Jpn J Ophthalmol; 2008; 52(1):68-70. PubMed ID: 18369705
[No Abstract] [Full Text] [Related]
18. Latanoprost and cystoid macular edema in high-risk aphakic or pseudophakic eyes.
Wand M; Gaudio AR; Shields MB
J Cataract Refract Surg; 2001 Sep; 27(9):1397-401. PubMed ID: 11566522
[TBL] [Abstract][Full Text] [Related]
19. New topical medications in the treatment of glaucoma.
Gandham SB
J Ophthalmic Nurs Technol; 1997; 16(6):290-1. PubMed ID: 9460417
[TBL] [Abstract][Full Text] [Related]
20. Severe hypotony following cataract extraction in a patient on latanoprost.
Wu G; Morrell A
Eye (Lond); 2000 Dec; 14(Pt 6):915-6. PubMed ID: 11584861
[No Abstract] [Full Text] [Related]
[Next] [New Search]
